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SUMMARY
Objective
To review studies on the perceptions, diagnosis and management of irrita-
ble bowel syndrome (IBS) in primary care.
Methods
Systematic searches of PubMed and Embase.
Results
Of 746 initial search hits, 29 studies were included. Relatively few primary
care physicians were aware of (2–36%; nine studies) or used (0–21%; six
studies) formal diagnostic criteria for IBS. Nevertheless, most could recog-
nise the key IBS symptoms of abdominal pain, bloating and disturbed defa-
ecation. A minority of primary care physicians [7–32%; one study (six
European countries)] preferred to refer patients to a specialist before mak-
ing an IBS diagnosis, and few patients [4–23%; three studies (two Euro-
pean, one US)] were referred to a gastroenterologist by their primary care
physician. Most PCPs were unsure about IBS causes and treatment effec-
tiveness, leading to varied therapeutic approaches and broad but frequent
use of diagnostic tests. Diagnostic tests, including colon investigations, were
more common in older patients (>45 years) than in younger patients
[<45 years; ﬁve studies (four European, one US)].
Conclusions
There has been much emphasis about the desirability of an initial positive
diagnosis of IBS. While it appears most primary care physicians do make a
tentative IBS diagnosis from the start, they still tend to use additional test-
ing to conﬁrm it. Although an early, positive diagnosis has advantages in
avoiding unnecessary investigations and costs, until formal diagnostic crite-
ria are conclusively shown to sufﬁciently exclude organic disease, bowel
investigations, such as colonoscopy, will continue to be important to pri-
mary care physicians.
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INTRODUCTION
Irritable bowel syndrome (IBS) is a functional bowel dis-
order that is characterised by abdominal pain, bloating
and disturbed defaecation.1 IBS affects an estimated 10–
15% of people in Western Europe and North America2–5
and 5–10% in Asia.6
Since no speciﬁc biological markers for IBS have been
identiﬁed, clinicians usually rely on symptom-based cri-
teria for diagnosis. A number of diagnostic tools have
been developed for use in IBS including the Rome crite-
ria, which were last revised in 2006,7 and the Manning
criteria.8 Diagnostic criteria have also been developed for
use in primary care.9 The Rome criteria are the most
widely accepted among gastroenterologists and are used
as research and diagnostic tools. However, according to
a recent systematic review, few studies have validated the
Rome I or Rome II criteria,10 and no consistent differ-
ences have been observed in the sensitivity or speciﬁcity
of the Rome I, Rome II and Manning criteria.11 Further-
more no studies have validated Rome III criteria,10 and
their uptake has been variable in clinical practice, possi-
bly because they were developed partly for research pur-
poses.10 There is still a need for development and
validation of diagnostic criteria in primary care practice,
to address patients’ and physicians’ concerns that organic
disease might be missed without endoscopy.
Treatment strategies for IBS are also based on the nat-
ure, type and severity of symptoms.2 Although generally
speaking the effectiveness of drug treatment in IBS is
limited, several treatments have been shown to be supe-
rior to placebo. These include anti-spasmodic agents and
drugs acting on the 5-hydroxytryptamine receptor for
diarrhoea-predominant IBS (IBS-D), soluble ﬁbre for
increasing stool-frequency in constipation-predominant
IBS (IBS-C), chloride channel agonists for IBS-C and
anti-depressants for chronic pain.12 In addition, several
psychotherapeutic interventions have established effec-
tiveness in IBS.13, 14 However, there is a need for further
consensus and guidance on which treatments should be
used for which patients with IBS, as was done recently
for probiotics.15
Less than half of those suffering from IBS consult a
physician.16 Although most clinical studies on IBS have
been performed in patients referred to gastroenterolo-
gists, the majority of patients are likely to present in pri-
mary care where their diagnosis and management is
initiated. Previous reviews of IBS in primary care have
focused on the interactions between PCPs and patients
with IBS,17 and on differences/similarities in IBS between
primary and secondary care.18 Here, we aimed to focus
on reviewing the literature on PCPs perceptions, under-
standing and views of IBS, including how they choose to
diagnose and manage this challenging problem.
METHODS
Search strategy
We employed broad systematic search terms aimed at
identifying any studies mentioning IBS and primary care
in the title/abstract, or indexed in PubMed under related
Mesh terms (Figure 1). PubMed ﬁlters were applied to
limit identiﬁed articles to those conducted in humans
and published in English in the last 20 years (up to 10
November 2013). This search strategy was adapted for
use in Embase, which was accessed via the online search
platform OvidSP. The results were screened by title and
abstract to exclude clearly irrelevant articles and those
not speciﬁcally examining IBS in primary care. Full
papers were obtained for the remaining articles to iden-
tify those providing insight into PCPs’ perceptions and
understanding of IBS in primary care, as well as its diag-
nosis and management in this setting. Owing to the
broad nature of the study question, more speciﬁc pre-
deﬁned inclusion criteria were not able to be applied.
The literature search was supplemented by relevant
papers from the authors’ own libraries. Screening of the
searches, data extraction and selection of the ﬁnal articles
was conducted by a single reviewer (MM-B) and inde-
pendently veriﬁed by a second reviewer (RC). A formal
assessment of the quality of the included studies was not
conducted for this review.
RESULTS
Identiﬁed studies
Overall, 29 studies were included (Figure 1 and Table
S1). Of these, 20 were conducted in Europe, seven in
North America, one in the Middle East and one in
Southeast Asia. The publication date ranged from 1997
to 2013 (median: 2006) and all studies collected data
using questionnaires, interviews and/or medical chart
reviews.
While a formal assessment of study quality was not
conducted, it should be noted that response rates for
study participation in the included studies were generally
low, and often not reported (Table S1). Furthermore,
while publication dates are included throughout this arti-
cle so they can be factored into the interpretation of
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the data, study periods were rarely reported. Unknown
variation in the time between study conduct and publica-
tion should therefore be acknowledged. Finally, much of
the data presented here pertains to PCPs’ perceptions
and views of IBS. Such data can only be obtained
through surveys, which have obvious limitations in terms
of bias. Other data, such as those on the use of diagnos-
tic tests, treatments and referral rates, were collected
using methods that vary in terms of their reliability. In
general (though not always), data gathered via medical
chart review will be less biased than questionnaire data,
and prospective questionnaires will be less biased than
Search results combined and 
duplicates removed:
604 studies
PubMed:
510 hits
Embase:
236 hits
93 studies 
Excluded (n = 511) based on title/abstract: 
•  Irrelevant study topic
•  IBS not specifically examined in primary care
Search string adapted for use in Embase (Emtree terms only): 
Publication date range: 1992–November 2013 
Filters: Humans, English language  
26 studies 
Excluded (n = 67) based on full-text article: 
•  Data not compatible with final scope of review (31)
•  Irrelevant publication type (25: reviews [11], guidelines [7], 
  commentaries [5], case report [1], editorial [1])
•  No primary care data (7)
•  Duplicate (2)
•  Unclear disease definition (1)
•  Patient population overlapped with another study (1)
included in
review 
Additional relevant 
studies from the 
authors’ own libraries 
(n = 3) 
PubMed Search string:
(IBS[title/abstract] OR ‘irritable bowel syndrome’[title/abstract] OR 
‘irritable bowel syndrome’[Mesh]) AND (’primary health care’[Mesh] OR 
‘primary health care’[title/abstract] OR ‘primary care’[title/abstract] OR 
‘physicians, primary care’[Mesh] OR ‘general practice’[Mesh] OR ‘general 
practitioners’[Mesh] OR ‘general practice’[title/abstract] OR ‘general 
practitioners’[title/abstract] OR  ‘family physician’[title/abstract] OR 
‘family practitioner’[title/abstract] OR ‘family practice’[title/abstract] OR 
‘physician's practice patterns’[Mesh] OR ‘clinical protocols’[Mesh] OR 
‘clinical practice’[title/abstract] OR ‘practice guidelines as topic’[Mesh])
Publication date range:  1992–November 2013
Filters: Humans, English language 
29 studies
Figure 1 | Flow diagram of literature searches. The PubMed and Embase searches were performed up to 11 Nov 2013,
and were limited to those conducted in humans and published in English in the last 20 years.
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those that are applied retrospectively (due to recall bias).
Data sources used are thus described throughout the
text, when this may aid in interpreting the reliability of
the data.
Use of diagnostic tests
Most PCPs in the European survey by Seifert et al.
(2008) used diagnostic tests for IBS, with 35% of Dutch
PCPs, 25% of British PCPs and less than 10% of PCPs
in other countries stating that they would not use diag-
nostic tests for IBS.19 These results are consistent with
other studies that show around two-thirds of patients
with IBS in primary care usually undergo some form of
diagnostic testing.20–22
Substantial variation exists in the types of diagnostic
tests used by PCPs for suspected IBS in primary care.
Across six European countries, 5–68% of PCPs surveyed
said they would employ faecal occult blood tests, 50–
75% would request an erythrocyte sedimentation rate test
and 5–67% would use colonoscopy (2008).19 In the US,
74% of PCPs surveyed said they would use faecal occult
blood tests, 48% would request erythrocyte sedimenta-
tion rate tests and 17% would test for coeliac disease
markers (2006).23 Other tests reported to be commonly
used by US PCPs in this study were complete blood
count (74% of PCPs), electrolyte (61%), liver (56%) and
thyroid function tests (36%).23 Figure 2 shows the
extreme variation in the types of diagnostic tests per-
formed in patients with IBS, based on database
records,21, 24, 25 and prospective questionnaires22 and
interviews.20 Other common tests not shown in Figure 2
included those for coeliac disease (16%),24 C-reactive
protein (27%),24 and thyroid function (15%24 and
36%22).
Factors inﬂuencing diagnostic approach
The age of both the patient and the PCP appears to have
a signiﬁcant impact on the diagnostic approach to IBS.
Yawn et al. (2001) found that US patients who were over
50 years of age had colon imaging tests nearly twice as
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Figure 2 | Diagnostic tests ordered for patients with irritable bowel syndrome by their primary care physician. Only
diagnostic tests for which data were available in at least two studies are included.
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often as patients under 50 years of age (based on medi-
cal chart review: 74% vs. 38%), an age cut-off often rec-
ommended for this diagnostic test.25 Similarly, 14% of
patients under 45 years of age received colon investiga-
tions compared with 58% of patients over 45 years of
age in a UK study, based on prospective interviews
(2000),20 and Italian PCPs in another study using pro-
spective questionnaires (2005) ordered a barium enema
more often for older (>50 years) patients than for youn-
ger patients (≤50 years) (35% vs. 11%; P < 0.001).22 In
the Netherlands, Bijkerk et al. (2003) found that 48% of
PCPs did not even consider diagnostic tests in patients
younger than 50 years.26 Rectoscopy was more frequent
in older (>45 years) vs. younger (≤45 years) patients
(P < 0.0001) based on medical chart review in the Swed-
ish study by Faresjo et al.24 Laboratory tests were also
more common in older patients, except for C-reactive
protein and tests for coeliac disease, which were more
frequent among younger patients (2006).24
Age (presumably a proxy for experience) also inﬂu-
enced diagnostic testing patterns in UK primary care in
the study by Thompson et al. (1997), with a higher pro-
portion of PCPs aged under (vs. over) 45 years of age
saying they never or rarely use certain tests for excluding
organic disease (barium enema: 65% vs. 21%; sigmoidos-
copy: 61% vs. 21%; occult blood tests: 56% vs. 26%;
small bowel x-ray: 93% vs. 88%; barium meal: 70% vs.
47%; ultrasound: 79% vs. 54%.27 In contrast, Bellini et al.
(2005) found that PCPs with more than 20 years of
experience requested diagnostic tests less often than
those with less experience (20% vs. 5%; P < 0.001), based
on data gathered using prospective questionnaires.22
In two studies [Italy (2005): prospective question-
naire22 and the US (2001): medical chart review21] there
was no difference in the frequency of requests for diag-
nostic tests between men and women. However, rectos-
copy was more frequent among women (P < 0.005) than
among men based on medical chart review in the study
by Faresjo et al. (2006).24 Laboratory tests were more
common for men than for women (78% vs. 71%;
P < 0.05, adjusted for age), with the exception of thyroid
hormone tests which were more frequent among
women.24
In US primary care, physicians who believed IBS to be
a diagnosis of exclusion ordered 1.6 more tests on aver-
age for IBS-D patients than those who did not, and con-
sumed $364 more on average per patient (2010).28
Similarly, in primary care in Denmark (2013),29 a strat-
egy of exclusion for diagnosing IBS cost more per patient
than a positive diagnostic strategy ($5075 vs. $3160)
Knowledge of symptoms and diagnostic criteria
Primary care physicians appear to be guided by key
symptoms of IBS (abdominal pain, altered bowel habits
and bloating). In a study conducted in Saudi Arabia
(2012), 97% of PCPs recognised abdominal pain as a
symptom of IBS, followed by 83% for altered bowel habit
and 77% for bloating.30 Bijkerk et al. (2003) found that
63% of PCPs in the Netherlands considered recurrent
abdominal pain lasting more than 3 months as crucial
for diagnosing IBS.26 PCPs in the UK and the Nether-
lands (2009) deﬁned IBS as a combination of symptoms
with no explained organic cause, focusing on changed
defaecation pattern and abdominal pain.31 Similarly, Bel-
lini et al. (2005) found that PCPs in Italy considered the
most important symptoms for diagnosing IBS to be
changes in bowel habits (96%), abdominal pain/discom-
fort relieved by evacuation (82%) and abdominal bloat-
ing (79%).22 Nearly half of US PCPs could identify
typical IBS symptoms in another study (2003).32 Across
nine studies, few PCPs (2–36%, median 20.5) had heard
of formal criteria for IBS (Rome I, Rome II or Manning;
Figure 3a).19, 22, 26, 27, 32–36
Use of diagnostic criteria
The proportion of PCPs saying that they used formal
diagnostic criteria to diagnose IBS was low across six
studies (Figure 3b),19, 22, 27, 33–35 with one exception
from a survey of Romanian PCPs (2006) in which 99%
stated that they used Rome II diagnostic criteria for IBS;
the participants had recently attended courses on IBS
and functional bowel disorders (study not included in
Figure 3).
Five European studies assessed the proportion of IBS
diagnoses made by PCPs that also met Manning or
Rome criteria for IBS (Table 1).20, 26, 37–39 The highest
speciﬁcity was observed for Rome III criteria in a study
conducted in Denmark by Engsbro et al. (2013), with
75% of 499 patients diagnosed with IBS by their PCP
meeting these criteria.38 However, the methodology used
in this article may have biased towards a high speciﬁcity
for Rome III criteria. PCPs who participated were asked
to recruit all patients aged 18–50 years who they consid-
ered to have IBS. While not formally provided with
information about diagnostic criteria by the investigators,
it is hard to imagine that PCPs would not seek out crite-
ria for IBS upon entry into such a study. Furthermore,
PCPs who are already conﬁdent in diagnosing IBS may
be more inclined towards participation than those who
are not. Interestingly, the lowest speciﬁcity for IBS diag-
nostic criteria was also reported for the Rome III criteria
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ª 2014 John Wiley & Sons Ltd
Systematic review: IBS perceptions in primary care
(24%).37 The data-collection period for this study
occurred before Rome III criteria were published, and
may thus provide a truer reﬂection (though only in one
country) of the extent to which formal diagnostic criteria
for IBS line up with how PCPs tend to diagnose this
disease.
The sensitivity of the Rome II criteria was low (18–
39%) in the three studies reporting these data.26, 37, 39 In
two studies, 20% (Norway)39 and 0% (Thailand)40 of
patients meeting Rome II criteria and Rome III criteria,
respectively, were subsequently diagnosed with IBS by
their PCP.
Diagnostic conﬁdence
Several lines of evidence suggest that most PCPs con-
sider IBS to be a diagnosis of exclusion (i.e. organic
causes should be excluded before diagnosing IBS). These
include: structured interviews where this view was given
by PCPs (2009 and 2013),31, 41 including one study
(2010) in which 72% of PCPs expressed this view;28 the
high proportion of PCPs across studies (49–65%; 1997–
2006) that rank the exclusion of organic disease as their
primary concern;23, 26, 27 and the high frequency of diag-
nostic testing among PCPs (see previous section ‘Use of
diagnostic tests’).19–21
Despite the prevalent belief among PCPs that IBS is a
diagnosis of exclusion they are largely conﬁdent that
they can make a diagnosis of IBS themselves. In the US
study by Longstreth et al. (2003), PCPs ranked IBS as
fourth behind heartburn, back pain and headache in
terms of diagnostic conﬁdence,32 while UK PCPs did not
regard IBS as more difﬁcult to distinguish from organic
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Figure 3 | (a) Awareness and (b) use of formal diagnostic criteria for IBS. Reference numbers of the corresponding
studies are shown beside data points.
Table 1 | Overlap between primary care physician (PCP)- and criteria-based diagnosis of irritable bowel syndrome
(IBS)
Country
Dates
conducted
Manning
(1978)
Rome I (1992)
or Manning (1978)
Rome II
(1996)
Rome III
(2006)
% of patients with PCP IBS diagnosis who met IBS criteria
Bijkerk et al., 2003 The Netherlands NS 62 – 18 –
Thompson et al., 2000 UK 1995 – 82 – –
Anastasiou et al., 2008 Greece 1996–2000 69 – 32 24
Vandvik et al., 2004 Norway 2001 – – 39 –
Engsbro et al., 2013 Denmark 2008–2010 – – – 75
% of patients meeting IBS criteria who were diagnosed with IBS by PCP
Thompson et al., 2000 UK 1995 – 58 – –
Vandvik et al., 2004 Norway 2001 – – 20 –
Thanapirom et al. 2012
(abstract)
Thailand 2012 – – – 0
NS, not speciﬁed.
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disease than pelvic pain, headache or backache in the
study by Thompson et al. (1997).27 In the latter study,
37% of PCPs felt able to diagnose IBS over 50% of the
time at the initial visit without further testing. In the
study by Lacy et al., 53% of PCPs in the US felt ‘very
comfortable’ making a new IBS diagnosis at the initial
visit in the absence of alarm signs.23
Referral rates
In the European survey by Seifert et al. (2008), the pro-
portion of PCPs who would seek specialist referral before
making a diagnosis of IBS was 7% in the Netherlands,
10–15% in England, 15–20% in Spain, and 25–32% for
Greece, Poland and the Czech Republic.19
The proportion of patients with IBS referred by their
PCP to a gastroenterologist was similar based on pro-
spective questionnaires in two European studies report-
ing data [20% (2000)20 and 23% (2005)22], but lower in
one US study [4% (2001)].25 In Saudi Arabia, 40% of
PCPs surveyed said that they would eventually refer an
IBS case to a gastroenterologist.30 The proportion of
PCPs referring patients with IBS to a mental health pro-
vider was similar in two studies using prospective ques-
tionnaires that reported these data [9% (2004)42 and
12% (2005)22]. Referral to a dietician was also common
in these studies (7%22 and 8%42) as was referral to a
gynaecologist in one of the studies (19%).22
Factors inﬂuencing referral
A variety of reasons for referral of patients with IBS
by PCPs were reported across studies. In one US
(2006)23 and two European studies [Germany (2009)33
and the UK (1997)27], 18–64% of patients were
referred because of an unclear diagnosis and 24–54%
were referred owing to insufﬁcient therapeutic response
or patient dissatisfaction. Less than a quarter of the
US patients (2006)23 and 16% of Italian patients in
another study (2006)43 were referred to a specialist
because they needed reassurance, while 3% and 34%
of referrals were at the request of the patient in the
studies conducted in Germany (2009)33 and Italy
(2006),43 respectively. The most common reason for
referral for the US patients was the presence of alarm
features, while the three most common reasons for
referral to a psychiatrist were co-existing anxiety or
depression, history of physical or sexual abuse and
symptoms refractory to therapy.23 Denial of a role for
stress in IBS was a signiﬁcant predictor of referral to
a specialist by UK PCPs after logistic regression, as
was multiple diagnostic testing and the presence of
frequent bowel movements, in a study by Thompson
et al. (2000).20
Thompson et al. (1997) found a higher proportion of
male doctors than female doctors said they referred their
patients (18% vs. 7%) based on retrospective question-
naires administered in the UK, and referral rates were
also higher for older doctors (43–60 years old) compared
with younger doctors (31–42 years old) in this study
(19% vs. 10%).27 PCPs’ decisions regarding referrals did
not seem to vary with clinical presentation or patient age
in Italian patients (2005),22 or in relation to IBS subtype
in US patients (2006),23 according to prospectively
applied questionnaires.
Views on aetiology and pathophysiology
Most PCPs recognise that psychological comorbidities
are common in IBS but opinions vary about their aetio-
logical signiﬁcance. Across three studies [Saudi Arabia
(2012), the Netherlands (2003) and the US (2006)], 55–
71% of PCPs identiﬁed stress, anxiety (or ‘nervousness’)
and depression as being associated with symptoms of
IBS,23, 26, 30 while 45% of UK PCPs agreed that IBS is a
nervous complaint in another study (2004).44 Casiday
et al. (2009) reported that PCPs frequently saw IBS as a
consequence of disordered bowel activity in response to
stress.31
Two studies, which between them covered seven Euro-
pean countries [Czech Republic, Greece, the Netherlands,
Poland, UK and Spain (2008),19 and Germany (2009)33],
reported that about a quarter to two-thirds of PCPs
believed IBS had a psychiatric or psychological compo-
nent, while none thought so in another study in Roma-
nia (2006).45 In other studies, 49% of UK PCPs thought
IBS was psychosomatic (2003),34 while psychological and
psychiatric factors were ranked second by Italian PCPs
(after intestinal motility disorder) as the most probable
cause of IBS symptoms (2005).22 Another study in UK
primary care by Thompson et al. (1997) found that 87%
of PCPs thought IBS aetiology was sometimes physical
and sometimes psychological; however, only 14% and
7% would apply a psychological or psychiatric label,
respectively.27
There are also differences in PCPs’ views of the aetio-
logical signiﬁcance of visceral pain sensitivity, motility,
enteric infection and sexual abuse. Gut hypersensitivity
was believed to be an aetiological factor for IBS by 26%
of Dutch PCPs (2003)26 and 54% of US PCPs (2006).23
The latter study also found that most PCPs believed IBS
was a disorder of both gut hypersensitivity and gastroin-
testinal motility.23 The proportion of PCPs who consid-
Aliment Pharmacol Ther 2014; 40: 1133-1145 1139
ª 2014 John Wiley & Sons Ltd
Systematic review: IBS perceptions in primary care
ered IBS to be a motility disorder ranged from 2% in
Romania (2006),45 to 62% in the US (2006),23 and 49%
and 62% in Germany (2009)33 and the Netherlands
(2003),26 respectively. In one study (2009),31 Dutch PCPs
considered smoking, caffeine, diet, ‘hasty lifestyle’ and
lack of exercise as other possible triggers of IBS symp-
toms, while UK PCPs considered food, infection and tra-
vel as other possible triggers.31 The proportion of PCPs
who believe infection or food intolerance causes IBS was
low (<5%) in Saudi Arabia (2012)30 and the Netherlands
(2003).26
Views on IBS management
Relief of symptoms was rated by US PCPs as their sec-
ond greatest concern behind excluding organic disease,
with only 22% rating this as their main objective
(2006).23 In contrast, 73% believed that symptom relief
was the patients’ primary concern.
Despite widely held beliefs that IBS has a psychologi-
cal component [three UK studies (1997–2013); one
European study (six countries; 2008); one Italian study
(2005) and one German study (2009)],19, 22, 27, 33, 34, 41
PCPs are often reluctant to consider mental health inter-
ventions (2013 and 2004; UK).41, 46 Reasons for this
include a lack of familiarity with such interventions, per-
ceived patient resistance to psychological treatment and
doubts of the strength of evidence for psychological
intervention (2004; UK),46 as well as the belief that the
condition can be managed effectively and adequately in
primary care (2013 and 2004; UK).41, 46
In terms of perspectives on the effectiveness of IBS
treatment, Cox et al. (2004) found that 40% of PCPs in
the UK study agreed that IBS responded mainly to the
placebo effect of personal care and attention, and most
(61%) were unsure about or disagreed with the statement
that IBS symptoms mainly respond to medical therapy.44
Most PCPs were also unsure about or disagreed with the
statements that existing treatment regimens (54%) or
dietary advice (59%) are effective.44 In the same study,
73% and 77% of PCPs agreed that hypnotherapy could
help patients with physical and psychological problems,
respectively.44
Management approaches
UK PCPs in the study by Casiday et al. (2009) stated
that their main focus was managing symptoms and reas-
suring patients with IBS.31 In terms of management
goals for pharmacotherapy, Bijkerk et al. (2003) found
that 70% of Dutch PCPs considered global symptom
improvement to be their main aim, while 28% aimed
mainly to improve predominant IBS symptoms and 2%
aimed mainly to improve quality of life.26 In this study,
93% of respondents said they provided dietary advice to
their patients, 77% used counselling, 63% gave routine
lifestyle advice, 55% prescribed drug therapy and 4%
provided behavioural therapy.26 A similarly high propor-
tion of 70 PCPs surveyed in the Icelandic study by
Olafstdottir et al. (2012) said they provided dietary
advice (98%) and education about IBS (90%); advice
around relaxation and exercise was less common
(~15%).36 Counselling and patient education were only
provided for 18% of patients with IBS in the 3 years
after diagnosis in one US study (2001).21 In another
study in US primary care (2004) that used prospective
questionnaires, 55% of patients with IBS received educa-
tion about the cause of their symptoms, 63% received
dietary advice, 50% exercise advise and 37% lifestyle
advice on how to reduce stress.42
Among German PCPs, 96% of those surveyed stated
that they prescribed drug therapy, while psychotherapy
and alternative therapies (such as homoeopathy, acu-
puncture, phytotherapy dietary therapy or probiotics)
were recommended by 55% and 61% of PCPs, respec-
tively (2009).33 Only 8% of US primary care patients
with IBS were referred to naturopaths in the study by
Whitehead et al. (2004),42 based on prospective ques-
tionnaires.
Most UK and Dutch PCPs surveyed by Casiday et al.
(2009) said they prescribed ﬁbre for IBS.31 The UK PCPs
said they readily prescribed medications, while the Dutch
PCPs preferred not to prescribe any drugs, unless
requested by the patient, based on a belief that limited
evidence for efﬁcacy exists.31
Figure 4 shows the large variation in the types of
medications used to treat IBS in primary care in terms
of the proportion of PCPs prescribing based on retro-
spective questionnaires,26, 30, 36 while Figure 5 shows the
actual medications received by patients based on data-
base records,21, 24 prospective22 and retrospective42, 47
questionnaires.
Factors inﬂuencing management approaches
In the Swedish study by Faresjo et al. (2006), all pre-
scriptions for IBS increased with increasing age except
for anti-diarrhoeal agents, which were more common
among younger patients based on medical chart review.24
Prescription of anti-depressants was independently asso-
ciated with being female (P < 0.03).24 In the only other
study reporting such data (2001), which also used data
from medical charts, women in the US with IBS were
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slightly more likely to use medications for bowel dys-
function (laxatives and antidiarrhoeals) than men
(P = 0.05), and men were more likely to have prescrip-
tions for histamine blockers (P = 0.01), anti-depressants
and anti-anxiety medications (P = 0.03).21
DISCUSSION
Most PCPs consider IBS to be a diagnosis of exclusion,
but one that can be reached in primary care. There has
been much emphasis recently about the desirability of an
initial positive diagnosis. While it appears that most
PCPs do make a tentative IBS diagnosis from the start,
they still tend to use additional testing to conﬁrm it.
To our knowledge, this is the ﬁrst systematic review of
published studies providing insight into the perceptions,
diagnosis and management of IBS, speciﬁcally from a pri-
mary care perspective. The main limitation of this review
relates to the large variety of data reported, which make it
difﬁcult to draw clearly deﬁned conclusions. Another limi-
tation is that only broad pre-deﬁned selection criteria
could be applied owing to the wide scope of the study
question. Furthermore, like any review seeking to capture
current thinking in an ever-evolving ﬁeld, it is inevitable
that some of the data presented here no longer represent
current practice and that newer trends have not yet made
it into the literature. In terms of the quality of the included
studies, some were based on retrospectively applied ques-
tionnaires, which are prone to recall bias, although many
studies, including those reporting diagnostic tests used
and medications prescribed in patients with IBS, used
more reliable methods such as prospective questionnaires
and interviews, and medical records. Despite the limita-
tions, this is the most comprehensive assessment yet of
this topic and we believe some useful, though tentative,
inferences can be drawn.
We have attempted to synthesise papers from across
countries – this strengthens the article in scope but
reduces the generalisability of conclusions because of
locally prevailing factors. In particular, differences in
healthcare systems across countries will have a bearing
on the way patients are diagnosed and managed further.
In settings where there is a clear delineation between pri-
mary and secondary care referral is likely to be restricted
to patients whose diagnosis is uncertain or to situations
where factors such as patient reticence drive towards a
specialist opinion or colonoscopy. For example, in the
UK, economic pressures to reduce specialist referrals and
colonoscopy mean that primary care management of IBS
predominates. In countries with a mixed system,
whereby specialists work in the community, barriers to
specialist investigations may be reduced and the preva-
lence of such diagnostic strategies is thus likely to be
higher. Factors underlying which diagnostic strategies
predominate in different countries include the type of
reimbursement system, the level of easy (and low cost)
access to investigational services and how the consulting
clinician is incentivised. These differences may even be
localised within countries, for example between those
patients who are privately insured and those entirely
within the state system.
Primary care physicians have a heterogenous view of
the causes of IBS. Their perceptions of the factors associ-
ated with IBS were related to the presence of stress and
nervousness, with some indicating that gut hypersensitiv-
ity plays a role, and a very small fraction identifying
food allergies as a factor. No obvious single explanatory
model for the symptoms of IBS itself was discernible,
which is probably why treatment approaches were found
to vary so greatly. Relatively few PCPs had heard of
Manning or Rome diagnostic criteria, and still fewer
used them in their practice, though recent studies assess-
ing the awareness or use of Rome III criteria were lack-
ing. Despite a lack of awareness and use of formal
diagnostic criteria for IBS, most PCPs could identify typ-
ical symptoms of IBS.
Contrary to the views of many outside primary care,
the literature indicated that PCPs do not, in general,
make an immediate, positive diagnosis of IBS but access
tests, including colonoscopy, to exclude other problems.
This follows the necessarily global approach that PCPs
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need to take in patients presenting with heterogeneous
symptoms from different possible causes. An example is
cough, which in the vast majority of cases is a simple,
self-limiting problem, but for which a lack of vigilance
may result in a serious lesion being missed. An equiva-
lent situation exists for IBS and for many PCPs this
means they will test early. In this study diagnostic man-
agement in IBS varied largely between different health-
care settings, resulting in a wide variation in conﬁdence
about diagnosing IBS. Diagnostic testing by PCPs was
very common overall, though the types of tests used var-
ied greatly. Taking the above factors into consideration,
in combination with the low proportion of PCPs who
would seek a specialist referral before making a diagnosis
of IBS (7–32%),19 it appears that most PCPs consider
IBS to be a diagnosis of exclusion, but one that can be
reached in primary care.
The use of multiple diagnostic tests to exclude IBS
and uncertainty around treatment approaches seems to
be reﬂected by patients’ experience of primary care,
which can leave some feeling confused and frus-
trated.48, 49 Only a small proportion of patients with IBS
(4–23%)20, 22, 25 are referred to secondary care. Reasons
for referral include an unclear diagnosis, insufﬁcient
therapeutic response (which, ironically is a common fac-
tor in IBS and not necessarily bettered in secondary
care) and patient dissatisfaction. Primary care physicians
lack consensus on the best conceptual model for under-
standing IBS: they exhibit regional differences in their
beliefs about aetiology, diagnosis, the role of psychologi-
cal factors and treatment guidelines. Although much var-
iation exists between PCPs in different settings in terms
of their diagnostic and management behaviour, the diag-
nosis of IBS is mainly based on excluding other prob-
lems, even if a tentative diagnosis is made early.
Diagnostic criteria, mainly established from secondary
care, are largely unknown or not applied in primary
care, at least according to the most recent literature.
Stress and other psychological factors are considered an
important part of IBS in primary care.
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Combined with perceived uncertainties and the stress
of getting things wrong the PCP is often in a difﬁcult posi-
tion. It is important to appreciate that uncertainty and a
lack of conﬁdence in a symptom-based positive diagnosis
of IBS greatly inﬂuences clinical behaviour, particularly
when progress is not made with the patient and available
options are rapidly exhausted. It is therefore not surprising
that many PCPs adapt their practice towards early investi-
gation. While a positive diagnosis of IBS by PCPs in
low-risk patients would be less costly than a diagnosis of
exclusion, this is not the way most PCPs practice. Further-
more, there is evidence that none of the formal diagnostic
criteria currently available sufﬁciently, conclusively distin-
guish IBS from organic diseases.50 Until this changes,
bowel investigations, such as colonoscopy, will continue to
be important for PCPs to exclude organic disease and, par-
adoxically, there may be calls for this to be made more eas-
ily available; often differences in diagnostic strategies are
related to health care systems and their limitations. The
ongoing development of new diagnostic algorithms, based
on symptoms, comorbidity and psychosocial proﬁle, in
combination with new biomarker point-of-care tests, such
as for calprotectin, should facilitate and support more efﬁ-
cient discrimination between organic and functional bowel
disease by PCPs and reduce the use of lower GI endos-
copy. Further educational initiatives alone and dissemina-
tion of diagnostic criteria may be insufﬁcient – while an
early, positive diagnosis of IBS in primary care is likely to
be accurate and efﬁcient there are many barriers before
this is accepted in pragmatic practice. Specialists, too, will
need to align with this ethic if it is not to be undermined.
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